Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
97.35
Change Change %
2.95 3.12%

Updated:02 Jun, 2020, 14:34 PM IST

BSE
97.10
Change Change %
2.70 2.86%

Updated:02 Jun, 2020, 14:39 PM IST

Bliss GVS Pharma's 5 Years Financial Summary

Parameters MAR'18
(₹ Cr.)
MAR'17
(₹ Cr.)
MAR'16
(₹ Cr.)
MAR'15
(₹ Cr.)
MAR'14
(₹ Cr.)
Net Profit Before Taxes 86.84 94.91 100.21 91.25 82.30
Adjustments for Expenses & Provisions 0.77 28.12 7.21 14.91 6.89
Adjustments for Liabilities & Assets -29.06 -47.37 -27.78 -50.62 8.78
Cash Flow from operating activities 22.67 38.48 59.61 15.35 64.71
Cash Flow from investing activities 22.27 -29.34 -10.29 -21.49 -24.00
Cash Flow from financing activities -21.91 -14.77 -35.34 -31.23 -49.97
Effect of exchange fluctuation on translation reserve 0.00 0.00 0.00 0.00 0.00
Net increase/(decrease) in cash and cash equivalents 23.03 -5.63 13.98 -37.37 -9.26
Opening Cash & Cash Equivalents 7.33 12.95 3.40 38.70 52.58
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0.00 0.00 0.00 0.00 0.00
Cash & Cash Equivalent of Subsidiaries under liquidations 0.00 0.00 0.00 0.00 0.00
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0.00 0.00 0.00 0.00 0.00
Effect of Foreign Exchange Fluctuations 0.00 0.00 -4.43 2.07 0.00
Closing Cash & Cash Equivalent 30.36 7.33 12.95 3.40 43.32
Top
Listen to the latest songs, only on JioSaavn.com